News

Pharmabiz54m
NS Pharma announces alliance with Boston Children’s Hospital to develop new therapies for rare diseases
NS Pharma announces alliance with Boston Children’s Hospital to develop new therapies for rare diseases: Paramus, New Jersey Friday, July 4, 2025, 12:00 Hrs [IST] Paramus-headqu ...
Pharmabiz1h
US FDA clears Instil Bio’s IND application for AXN-2510, a PD-L1xVEGF bispecific antibody, for a phase 1 trial in relapsed/refractory solid tumours
US FDA clears Instil Bio’s IND application for AXN-2510, a PD-L1xVEGF bispecific antibody, for a phase 1 trial in relapsed/refractory solid tumours: Dallas Friday, July 4, 2025, ...
Pharmabiz2h
SonoClear receives US FDA breakthrough designation for its SonoClear system for use in intracranial ultrasound procedures
SonoClear receives US FDA breakthrough designation for its SonoClear system for use in intracranial ultrasound procedures: Oslo, Norway Friday, July 4, 2025, 10:00 Hrs [IST] SonoC ...
Pharmabiz1h
Zyla Health expands in Southeast Asia, empowering patients with personalised digital therapeutics
Zyla Health expands in Southeast Asia, empowering patients with personalised digital therapeutics: Our Bureau, Mumbai Friday, July 4, 2025, 11:30 Hrs [IST] Zyla Health, India’s ...
Pharmabiz3h
Novartis announces top-line results from phase III GCAptAIN study of Cosentyx in giant cell arteritis
Novartis announced top-line results from the phase III GCAptAIN study evaluating Cosentyx (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the study, Cosentyx ...
Pharmabiz19h
KSPC launches maiden virtual simulation-based pharma manufacturing training programme
KSPC launches maiden virtual simulation-based pharma manufacturing training programme: Our Bureau, Bengaluru Thursday, July 3 ...
Pharmabiz4h
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma: Nandita Vijayasimha, Friday, July 4, 2025, 08:00 Hrs [IST] Lifesciences industry ...
Pharmabiz4h
Pharmac South 2025 to kick off today at Chennai Trade Centre
The 10th edition of Pharmac South, the high-powered pharmaceutical and nutraceutical trade show, will open its doors today at the Chennai Trade Centre at Nandambakkam. The two-day event, running ...
Pharmabiz4h
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge: Nandita Vijayasimha, Bengaluru Friday, July 4, 2025, 08:00 Hrs [IST] The pharmace ...
Pharmabiz4h
India and Myanmar in talks to fast-track approval for pharma products in Myanmar
India and Myanmar in talks to fast-track approval for pharma products in Myanmar: Shardul Nautiyal, Mumbai Friday, July 4, 2025, 08:00 Hrs [IST] In a major development to boost ph ...
Pharmabiz4h
Govt to amend Rules to move preparations with higher alcoholic content to Schedule H1
Govt to amend Rules to move preparations with higher alcoholic content to Schedule H1: Gireesh Babu, New Delhi Friday, July 4, 2025, 08:00 Hrs [IST] The Drugs Consultative Committ ...
Pharmabiz18h
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Thursday, July 3 ...